© 2023 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
In case you missed it: Feb. 7 to Feb. 11
A look back on this week's news.
Optimal prenatal opioid use disorder care may reduce odds of preterm birth
An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.
Marijuana exposure during pregnancy may increase adverse birth outcomes
A review and meta-analysis in JAMA Network Open revealed women exposed to marijuana in pregnancy were at significantly increased risk for adverse neonatal outcomes, including low birth weight, small for gestational age, and preterm delivery.
A noninfectious "infection" after cesarean delivery
Experts evaluate 3 clinical scenarios and determine the appropriate course of action.
CooperSurgical to acquire the Cook Medical’s Reproductive Health division
CooperSurgical, Inc, a global provider of health products for women, babies, and families, announced Monday plans to acquire the Reproductive Health division of Cook Medical, a manufacturer for minimally invasive medical devices in the fertility, obstetrics, and gynecology markets.
The current state of uterine fibroid care
“Over 70% of women are estimated to develop uterine fibroids by age 50,” said senior author Irene Aninye, PhD, chief science officer for the Society for Women’s Health Research (SWHR) in Washington, D.C. “Fibroids are a complex condition that can range from being asymptomatic to having deleterious effects on a woman’s health and quality of life.”